Newsroom

Arm with a band-aid - symbolic image after vaccination
News
The World Health Organization (WHO) recently published a new position paper on COVID-19 vaccines. Dr. Henning Jacobsen, a researcher in the department “Viral Immunology” at the Helmholtz Centre for Infection Research (HZI), supported the WHO as an external advisor and contributed to the paper. The updated recommendations focus on people at increased risk of severe COVID-19. With the upcoming cold and flu season in mind, the paper provides a good reason to get your vaccination status checked.
13.10.2026
Macrophages under an electron microscope
News
Pulmonary fibrosis is currently incurable and leads to increasing shortness of breath. An international research consortium involving the Helmholtz Centre for Infection Research (HZI) and coordinated by Hannover Medical School (MHH) is now developing an innovative therapeutic approach as part of the BREATH-EC project: Genetically modified immune cells (macrophages) are designed to recognize pathological scarring processes and specifically inhibit them. The aim is to halt the progression of the disease and possibly even reverse it. The European Union (EU) is funding the project with around ten million euros.
12.10.2026
blue stick-shaped bacteria
News
Treatment with broad-spectrum antibiotics often leads to side effects, as it affects not only the pathogens but also the “good” bacteria in the gut. A research team from Hannover Medical School (MHH), Saarland University Hospital (UKS), and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now demonstrated that the natural compound argyrin B is highly effective against the pathogen Clostridioides difficile while largely sparing the beneficial gut microbiome. The researchers published their findings in the journal npj Antimicrobials and Resistance.
08.10.2026
Portrait of Jiteshkumar Deore in front of a gray wall
Portrait
Through the Helmholtz Global Fellow Program, the Helmholtz Association supports outstanding international researchers whose projects bring fresh scientific momentum to Helmholtz centers. One of these fellows is Dr Jiteshkumar Prakash Deore, who has been conducting research at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) since May 2026. In Dr Kenan Bozhuyuk’s group "Synthetic Biology of Microbial Natural Products", he is working on new synthetic biology platforms for the development of antimicrobial agents.
07.10.2026
Green rod-shaped bacteria
News
Why do the gut microbiomes of people from industrialized and non-industrialized regions differ? A study by the Helmholtz Centre for Infection Research (HZI) in collaboration with the European Molecular Biology Laboratory (EMBL), the University of Trento (Italy), and the University of Tübingen shows that diet alone does not explain these differences. In artificially assembled gut communities, the team examined numerous dietary components and demonstrated that plant-based dietary fiber shifted the balance in favor of the bacterium Segatella copri, which is particularly common in non-industrialized regions. However, the effect also depended on which other bacteria were present. The results were published in the journal Nature Microbiology.
06.10.2026
micrograph of an Asgard archaea cell
News
Asgard archaea, our closest known microbial relatives, play a key role in current models of the origin of more complex organisms, known as eukaryotes (all animals, plants, protists and fungi). However, their biology has so far been poorly understood. Microbiologists led by the University of Vienna in cooperation with the Helmholtz Centre for Infection Research (HZI) and the Institute of Science and Technology Austria demonstrate in a new study published in the journal Nature that these cells move through their environment in a surprisingly dynamic manner. These new findings enable the empirical testing of models for the origin of complex life for the first time.
02.10.2026

HZI in the media

Researchers at the Helmholtz Centre for Infection Research (HZI) and its Saarland University partner site, the Helmholtz Institute for

27.10.2026
|
Scienmag Science Magazine

experimental and modeling study led by scientists at the Helmholtz Centre for Infection Research in Braunschweig. The researchers found that

26.10.2026
|
Bioengineer.org

... am Helmholtz Zentrum für Infektionsforschung (HZI) und dessen Saarbrücker Standort, dem Helmholtz-Institut für Pharmazeutische ...

26.10.2026
|
Verband Deutscher Biologen e.V.

Dr. Milan Gerovac, Nachwuchsgruppenleiter am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, erhält den begehrten ...

24.10.2026
|
Homburg

heads the Research Group “Molecular Cell Biology” at the Helmholtz Center for Infection Research (HZI), has shed new light on the central

23.10.2026
|
Health Medicine Network

... “

 

Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung (HZI) untersuchen ...

22.10.2026
|
DeutschesGesundheitsPortal

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

22.10.2026
|
DIE WELT

... befallen. Am HZI in Braunschweig wird daran geforscht.

 

Am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig ...

22.10.2026
|
NDR Norddeutscher Rundfunk

are extremely complex.

 

Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now shown that artificial

21.10.2026
|
Phys.org

Würzburg (JMU) und dem Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des HZI in ...

20.10.2026
|
Regional Heute

community. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) that operates in collaboration with Saarland University.

20.10.2026
|
WDC Tv News

... Verabreichung eintritt. Expertin Berit Lange vom Helmholtz-Zentrum für Infektionsforschung betonte, dass jetzt der richtige Moment ...

16.10.2026
|
upday

Register now for the HZI newsletter